Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    ICHTHYOSIS, X-LINKED
Show Display Options
Rank Status Study
1 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
2 Recruiting STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Condition: Aortic Valve Stenosis
Intervention: Procedure: Transcatheter Aortic Valve Replacement
3 Terminated
Has Results
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
4 Completed Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: IPI-504
5 Recruiting Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pazopanib
6 Unknown  Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
7 Terminated Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Condition: Sarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin
8 Not yet recruiting Trabectedin Maintenance Post 1st-line in STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
9 Recruiting Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Conditions: Alveolar Soft Part Sarcoma;   Soft Tissue Sarcomas
Interventions: Drug: Axitinib;   Drug: Pembrolizumab;   Procedure: Blood Draw;   Procedure: Tumor Specimen Collection
10 Recruiting STS/ACC TVT Registry Mitral Module
Condition: Mitral Valve Regurgitation
Intervention: Device: Leaflet Clip
11 Active, not recruiting A Phase II Study of Anlotinib in STS Patients
Condition: Cancer
Intervention: Drug: Anlotinib
12 Recruiting Preoperative vs Postoperative IMRT for Extremity/Truncal STS
Condition: Adult Soft Tissue Sarcoma
Interventions: Radiation: Preoperative intensity modulated radiation therapy;   Radiation: Postoperative intensity modulated radiation therapy
13 Completed Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Bendamustin
14 Recruiting Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203)
Condition: Soft Tissue Sarcoma
Interventions: Drug: Anlotinib;   Drug: Placebo
15 Unknown  Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Trofosfamide
16 Completed
Has Results
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condition: Soft Tissue Sarcoma
Interventions: Procedure: External Beam Radiation Therapy (RT);   Biological: Autologous Dendritic Cells
17 Not yet recruiting Ph II Nintedanib or Intravenous Ifosfamide Advanced Metastatic STS Failed on Imatinib and Sunitinib
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Nintedanib;   Drug: Ifosfamide
18 Completed Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Carboplatin
19 Unknown  Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
20 Completed Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years